209 related articles for article (PubMed ID: 34615811)
41. Effects of Tilianin on Proliferation, Migration and TGF-β/Smad Signaling in Rat Vascular Smooth Muscle Cells Induced with Angiotensin II.
Cao W; Hu N; Yuan Y; Cheng J; Guo X; Wang Y; Wang X; Hu P
Phytother Res; 2017 Aug; 31(8):1240-1248. PubMed ID: 28620995
[TBL] [Abstract][Full Text] [Related]
42. Angiotensin-(1-7) decreases the expression of collagen I via TGF-β1/Smad2/3 and subsequently inhibits fibroblast-myofibroblast transition.
Zhou JP; Tang W; Feng Y; Li N; Gu CJ; Li QY; Wan HY
Clin Sci (Lond); 2016 Nov; 130(21):1983-1991. PubMed ID: 27543459
[TBL] [Abstract][Full Text] [Related]
43. Induction of LOX by TGF-β1/Smad/AP-1 signaling aggravates rat myocardial fibrosis and heart failure.
Lu M; Qin Q; Yao J; Sun L; Qin X
IUBMB Life; 2019 Nov; 71(11):1729-1739. PubMed ID: 31317653
[TBL] [Abstract][Full Text] [Related]
44. Angiotensin II induces skin fibrosis: a novel mouse model of dermal fibrosis.
Stawski L; Han R; Bujor AM; Trojanowska M
Arthritis Res Ther; 2012 Aug; 14(4):R194. PubMed ID: 22913887
[TBL] [Abstract][Full Text] [Related]
45. Salvianolic acid B exerts anti-liver fibrosis effects via inhibition of MAPK-mediated phospho-Smad2/3 at linker regions in vivo and in vitro.
Wu C; Chen W; Ding H; Li D; Wen G; Zhang C; Lu W; Chen M; Yang Y
Life Sci; 2019 Dec; 239():116881. PubMed ID: 31678285
[TBL] [Abstract][Full Text] [Related]
46. Suppression of SMOC2 reduces bleomycin (BLM)-induced pulmonary fibrosis by inhibition of TGF-β1/SMADs pathway.
Luo L; Wang CC; Song XP; Wang HM; Zhou H; Sun Y; Wang XK; Hou S; Pei FY
Biomed Pharmacother; 2018 Sep; 105():841-847. PubMed ID: 30021376
[TBL] [Abstract][Full Text] [Related]
47. Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition.
Kyung SY; Kim DY; Yoon JY; Son ES; Kim YJ; Park JW; Jeong SH
BMC Pharmacol Toxicol; 2018 Apr; 19(1):13. PubMed ID: 29609658
[TBL] [Abstract][Full Text] [Related]
48. Astragaloside effect on TGF-β1, SMAD2/3, and α-SMA expression in the kidney tissues of diabetic KKAy mice.
Wang Y; Lin C; Ren Q; Liu Y; Yang X
Int J Clin Exp Pathol; 2015; 8(6):6828-34. PubMed ID: 26261569
[TBL] [Abstract][Full Text] [Related]
49. FSP1-specific SMAD2 knockout in renal tubular, endothelial, and interstitial cells reduces fibrosis and epithelial-to-mesenchymal transition in murine STZ-induced diabetic nephropathy.
Loeffler I; Liebisch M; Allert S; Kunisch E; Kinne RW; Wolf G
Cell Tissue Res; 2018 Apr; 372(1):115-133. PubMed ID: 29209813
[TBL] [Abstract][Full Text] [Related]
50. Liensinine improves AngII-induced vascular remodeling via MAPK/TGF-β1/Smad2/3 signaling.
Jia P; Chen D; Zhu Y; Wang M; Zeng J; Zhang L; Cai Q; Lian D; Zhao C; Xu Y; Chu J; Lin S; Peng J; Lin W
J Ethnopharmacol; 2023 Dec; 317():116768. PubMed ID: 37308031
[TBL] [Abstract][Full Text] [Related]
51. Connective tissue growth factor expression after angiotensin II exposure is dependent on transforming growth factor-β signaling via the canonical Smad-dependent pathway in hypertensive induced myocardial fibrosis.
Wong CKS; Falkenham A; Myers T; Légaré JF
J Renin Angiotensin Aldosterone Syst; 2018; 19(1):1470320318759358. PubMed ID: 29575960
[TBL] [Abstract][Full Text] [Related]
52. Prolyl 4-Hydroxylase Domain Protein 3 Overexpression Improved Obstructive Sleep Apnea-Induced Cardiac Perivascular Fibrosis Partially by Suppressing Endothelial-to-Mesenchymal Transition.
Zhang GH; Yu FC; Li Y; Wei Q; Song SS; Zhou FP; Tong JY
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29051216
[TBL] [Abstract][Full Text] [Related]
53. Microvessel vascular smooth muscle cells contribute to collagen type I deposition through ERK1/2 MAP kinase, alphavbeta3-integrin, and TGF-beta1 in response to ANG II and high glucose.
Belmadani S; Zerfaoui M; Boulares HA; Palen DI; Matrougui K
Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H69-76. PubMed ID: 18456735
[TBL] [Abstract][Full Text] [Related]
54. Endothelial nitric oxide synthase-independent protective action of statin against angiotensin II-induced atrial remodeling via reduced oxidant injury.
Yagi S; Akaike M; Aihara K; Ishikawa K; Iwase T; Ikeda Y; Soeki T; Yoshida S; Sumitomo-Ueda Y; Matsumoto T; Sata M
Hypertension; 2010 Apr; 55(4):918-23. PubMed ID: 20194307
[TBL] [Abstract][Full Text] [Related]
55. Inhibitory effects of astragaloside IV on silica-induced pulmonary fibrosis via inactivating TGF-β1/Smad3 signaling.
Li N; Feng F; Wu K; Zhang H; Zhang W; Wang W
Biomed Pharmacother; 2019 Nov; 119():109387. PubMed ID: 31487583
[TBL] [Abstract][Full Text] [Related]
56. MiR-200a modulates TGF-β1-induced endothelial-to-mesenchymal shift via suppression of GRB2 in HAECs.
Zhang H; Hu J; Liu L
Biomed Pharmacother; 2017 Nov; 95():215-222. PubMed ID: 28846982
[TBL] [Abstract][Full Text] [Related]
57. CXCR7 attenuates the TGF-β-induced endothelial-to-mesenchymal transition and pulmonary fibrosis.
Guan S; Zhou J
Mol Biosyst; 2017 Sep; 13(10):2116-2124. PubMed ID: 28820530
[TBL] [Abstract][Full Text] [Related]
58. The miR-214-3p/c-Ski axis modulates endothelial-mesenchymal transition in human coronary artery endothelial cells in vitro and in mice model in vivo.
Wang J; Li H; Lv Z; Luo X; Deng W; Zou T; Zhang Y; Sang W; Wang X
Hum Cell; 2022 Mar; 35(2):486-497. PubMed ID: 34978047
[TBL] [Abstract][Full Text] [Related]
59. Suppression of TGF-β1/Smad signaling pathway by sesamin contributes to the attenuation of myocardial fibrosis in spontaneously hypertensive rats.
Zhao M; Zheng S; Yang J; Wu Y; Ren Y; Kong X; Li W; Xuan J
PLoS One; 2015; 10(3):e0121312. PubMed ID: 25793583
[TBL] [Abstract][Full Text] [Related]
60. DKK3 overexpression attenuates cardiac hypertrophy and fibrosis in an angiotensin-perfused animal model by regulating the ADAM17/ACE2 and GSK-3β/β-catenin pathways.
Zhai CG; Xu YY; Tie YY; Zhang Y; Chen WQ; Ji XP; Mao Y; Qiao L; Cheng J; Xu QB; Zhang C
J Mol Cell Cardiol; 2018 Jan; 114():243-252. PubMed ID: 29196099
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]